Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 26, 2018 - The FDA announced the discontinuation of Eisai's Hexalen (altretamine) capsules.
Return to publications